| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.1 |